EU Biotech Act postponed: time to act super now!

The European Commission has officially postponed the EU Biotech Act to the end of 2026 – a move welcomed by biotech stakeholders across Europe. The delay offers a crucial window to shape a regulatory framework that truly supports innovation, rather than stifling it. Hollandbio’s message is clear: the EU must act now for biotech. With global competition intensifying, Europe cannot afford to fall behind. Alongside other European biotech advocacy organisations, we take all available opportunity to push for smarter rules, better funding, and a stronger biotech ecosystem. Fingers crossed the EU uses this extra time wisely, building a future-proof, innovation-friendly framework. Now is the moment to get our act together and make biotech a cornerstone of Europe’s strategic future!